C&EN, 21 November 2021
|João Henriques - Team Leader|
|Paulo Lino - Scientist|
Up to 90% of the drugs in the pharmaceutical pipeline are classified as poorly soluble, according to the Biopharmaceutical Classification System. Amorphous solid dispersions have emerged as one of the preferred methods to increase aqueous solubility of drugs.
This webinar will focus on several aspects of the formulation screening of amorphous solid dispersions, for both the drug product intermediate and the final drug product. Register Now!
Key Learning Objectives:
- Overview of amorphous solid dispersion as an enabling technique in the pharmaceutical industry
- Screening methodologies for amorphous solid dispersions
- Drug product formulation of amorphous solid dispersions